Photo from wikipedia
This post hoc analysis of 6 randomized, double-blind, placebo-controlled trials assesses the efficacy and safety of dupilumab in patients with erythrodermic atopic dermatitis. Click to show full abstract
This post hoc analysis of 6 randomized, double-blind, placebo-controlled trials assesses the efficacy and safety of dupilumab in patients with erythrodermic atopic dermatitis.
Keywords:
patients erythrodermic;
erythrodermic atopic;
dupilumab patients;
efficacy safety;
atopic dermatitis;
safety dupilumab
Journal Title: JAMA Dermatology
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: JAMA Dermatology
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!